Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ALPHA-1-ANTICHYMOTRYPSIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 741 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Borgmann, S; Endisch, G; Urban, S; Sitter, T; Fricke, H
      A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis

      CLINICAL IMMUNOLOGY
    2. Melchior, SW; Noteboom, J; Gillitzer, R; Lange, PH; Blumenstein, BA; Vessella, RL
      The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy

      BJU INTERNATIONAL
    3. Tachikawa, H; Tsuda, M; Onoe, K; Ueno, M; Takagi, S; Shinohara, Y
      alpha-1-Antichymotrypsin gene A1252G variant (ACT Isehara-1) is associatedwith a lacunar type of ischemic cerebrovascular disease

      JOURNAL OF HUMAN GENETICS
    4. Janciauskiene, S; Krakau, T
      Alzheimer's peptide: A possible link between glaucoma, exfoliation syndrome and Alzheimer's disease

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    5. Yang, DS; Serpell, LC; Yip, CM; McLaurin, J; Chrishti, MA; Horne, P; Boudreau, L; Kisilevsky, R; Westaway, D; Fraser, PE
      Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    6. Wu, GH; Datar, RH; Hansen, KM; Thundat, T; Cote, RJ; Majumdar, A
      Bioassay of prostate-specific antigen (PSA) using microcantilevers

      NATURE BIOTECHNOLOGY
    7. Kanoh, Y; Ohtani, N; Ohara, T; Mashiko, T; Ohtani, S; Egawa, S; Baba, S; Ohtani, H
      Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, alpha(2)-macroglobulin, and their complexes

      ONCOLOGY REPORTS
    8. Janciauskiene, S
      Conformational properties of serine proteinase inhibitors (serpins) confermultiple pathophysiological roles

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    9. Okegawa, T; Noda, H; Ohta, M; Kato, M; Nutahara, K; Higashihara, E
      Use of various combinations of free, complexed and total prostate-specificantigen levels as predictors of the pathologic stage of prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    10. Takahashi, H; Fujita, S; Shibata, Y; Yamaguchi, A
      Adenomatoid odontogenic tumour: immunohistochemical demonstration of transferrin, ferritin and alpha-one-antitrypsin

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    11. Licastro, F; Pedrini, S; Davis, LJ; Caputo, L; Tagliabue, J; Savorani, G; Cucinotta, D; Annoni, G
      alpha-1-Antichymotrypsin and oxidative stress in the peripheral blood frompatients with probable Alzheimer disease: A short-term longitudinal study

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    12. Malatesta, M; Mannello, F; Sebastiani, M; Gazzanelli, G
      Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    13. Franceschi, C; Valensin, S; Lescai, F; Olivieri, F; Licastro, F; Grimaldi, LME; Monti, D; De Benedictis, G; Bonafe, M
      Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype

      AGING-CLINICAL AND EXPERIMENTAL RESEARCH
    14. Luboldt, HJ; Swoboda, A; Borgermann, C; Fornara, P; Rubben, H
      Clinical usefulness of free PSA in early detection of prostate cancer

      ONKOLOGIE
    15. Kourie, JI; Henry, CL
      Protein aggregation and deposition: Implications for ion channel formationand membrane damage

      CROATIAN MEDICAL JOURNAL
    16. Morgan, K; Licastro, F; Tilley, L; Ritchie, A; Morgan, L; Pedrini, S; Kalsheker, N
      Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations

      HUMAN GENETICS
    17. Mehta, PD; Pirttila, T; Patrick, BA; Barshatzky, M; Mehta, SP
      Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

      NEUROSCIENCE LETTERS
    18. Ki, CS; Na, DL; Kim, HJ; Kim, JW
      Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease

      NEUROSCIENCE LETTERS
    19. Lein, M; Jung, K; Elgeti, U; Petras, T; Stephan, C; Brux, B; Sinha, P; Winkelmann, B; Schnorr, D; Loening, SA
      Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis

      EUROPEAN UROLOGY
    20. Schroder, FH
      Diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA ranges

      EUROPEAN UROLOGY
    21. Mende-Mueller, LM; Toneff, T; Hwang, SR; Chesselet, MF; Hook, VYH
      Tissue-specific proteolysis of huntingtin (htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum

      JOURNAL OF NEUROSCIENCE
    22. Nilsson, LNG; Bales, KR; DiCarlo, G; Gordon, MN; Morgan, D; Paul, SM; Potter, H
      alpha-1-Antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease

      JOURNAL OF NEUROSCIENCE
    23. Lein, M; Jung, K; Hammerer, P; Graefen, M; Semjonow, A; Stieber, P; Ossendorf, M; Luboldt, HJ; Brux, B; Stephan, C; Schnorr, D; Loening, SA
      A Multicenter Clinical Trial on the use of alpha(1)-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis

      PROSTATE
    24. Scacchi, R; Ruggeri, M; Gambina, G; Martini, MC; Ferrari, G; Corbo, RM
      Plasma alpha 1-antichymotrypsin in Alzheimer's disease; relationships withAPOE genotypes

      NEUROBIOLOGY OF AGING
    25. Nilsson, LNG; Das, S; Potter, H
      Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphismon the expression of alpha(1)-antichymotrypsin in astrocytes: significancefor Alzheimer's disease

      NEUROCHEMISTRY INTERNATIONAL
    26. Charrier, JP; Tournel, C; Michel, S; Comby, S; Jolivet-Reynaud, C; Passagot, J; Dalbon, P; Chautard, D; Jolivet, M
      Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis

      ELECTROPHORESIS
    27. Rothbarth, K; Kempf, T; Juodka, F; Glaser, T; Stammer, H; Werner, D
      Intracellular location and nuclear targeting of the Spi-1, Spi-2 and Spi-3gene-derived serine protease inhibitors in non-secretory cells

      EUROPEAN JOURNAL OF CELL BIOLOGY
    28. Licastro, F
      Genetic background of inflammatory molecules affects protein expression, the risk of developing Alzheimer's disease and cognitive decline

      ARCHIVES OF GERONTOLOGY AND GERIATRICS
    29. Brawer, MK; Stamey, TA; Fowler, J; Droller, M; Messing, E; Fair, WR
      Perspectives on prostate cancer diagnosis and treatment: A roundtable

      UROLOGY
    30. Okegawa, T; Kato, M; Nutahara, K; Higashihara, E
      Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma

      UROLOGY
    31. Partin, AW; Marks, LS
      Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents

      UROLOGY
    32. Mahadeva, R; Sharples, L; Ross-Russell, RI; Webb, AK; Bilton, D; Lomas, DA
      Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis

      THORAX
    33. Obach, V; Revilla, M; Vila, N; Cervera, A; Chamorro, A
      alpha(1)-antichymotrypsin polymorphism - A risk factor for hemorrhagic stroke in normotensive subjects

      STROKE
    34. Kuriyama, M; Abrahamsson, PA; Imai, K; Akimoto, S; Deguchi, N; Shichiri, Y; Sugiyama, Y; Niwa, T; Inoue, T
      Determination of serum prostate-specific antigen-alpha(1)-antichymotrypsincomplex for diagnosis of prostate cancer in Japanese cases

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    35. Recker, F; Kwiatkowski, MK; Huber, A; Stamm, B; Lehmann, K; Tscholl, R
      Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: The Aarau experience

      JOURNAL OF UROLOGY
    36. Ellis, WJ; Etzioni, R; Vessella, RL; Hu, CC; Goodman, GE
      Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostatecancer

      JOURNAL OF UROLOGY
    37. Okihara, K; Fritsche, HA; Ayala, A; Johnston, DA; Allard, WJ; Babaian, RJ
      Can complexed prostate specific antigen and prostatic volume enhance prostate cancer detection in men with total prostate specific antigen between 2.5 and 4.0 ng./ml.

      JOURNAL OF UROLOGY
    38. Michel, S; Charrier, JP; Deleage, G; Battail-Poirot, N; Jolivet, M; Jolivet-Reynaud, C
      Analysis of prostate specific antigen and alpha 1-antichymotrypsin interaction using antipeptide monoclonal antibodies

      JOURNAL OF UROLOGY
    39. Skeel, A; Leonard, EJ
      alpha(1)-antichymotrypsin is the human plasma inhibitor of macrophage ectoenzymes that cleave pro-macrophage stimulating protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    40. Lindstedt, L; Lee, M; Kovanen, PT
      Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid

      ATHEROSCLEROSIS
    41. Jung, K; Stephan, C; Elgeti, U; Lein, M; Brux, B; Kristiansen, G; Rudolph, B; Hauptmann, S; Schnorr, D; Loening, SA; Sinha, P
      Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen < 4 mu g/L: Are they useful tools for early detection and screening of prostate cancer?

      INTERNATIONAL JOURNAL OF CANCER
    42. Qiu, ZH; Naten, DL; Liston, JC; Yess, J; Rebeck, GW
      A novel approach for studying endogenous A beta processing using cultured primary neurons isolated from APP transgenic mice

      EXPERIMENTAL NEUROLOGY
    43. Wang, YC; Liu, HC; Liu, TY; Hong, CJ; Tsai, SJ
      Genetic association analysis of alpha-1-antichymotrypsin polymorphism in Parkinson's disease

      EUROPEAN NEUROLOGY
    44. Ho, LI; Harn, HJ; Chen, CJ; Tsai, NM
      Polymorphism of the beta(2)-adrenoceptor in COPD in Chinese subjects

      CHEST
    45. Nurmikko, P; Pettersson, K; Piironen, T; Hugosson, J; Lilja, H
      Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys(145)-Lys(146)

      CLINICAL CHEMISTRY
    46. Semjonow, A; Oberpenning, F; Weining, C; Schon, M; Brandt, B; De Angelis, G; Heinecke, A; Hamm, M; Stieber, P; Hertle, L; Schmid, HP
      Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?

      CLINICAL CHEMISTRY
    47. Peter, J; Unverzagt, C; Krogh, TN; Vorm, O; Hoesel, W
      Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry

      CANCER RESEARCH
    48. Southwick, PC
      The role of free PSA in the detection of prostate cancer

      LABORATORY MEDICINE
    49. Gladysheva, IP; Popykina, NA; Zamolodchikova, TS; Larionova, NI
      Interaction between duodenase and alpha(1)-proteinase inhibitor

      BIOCHEMISTRY-MOSCOW
    50. Picken, MM
      The changing concepts of amyloid

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    51. Friis, H; Gomo, E; Koestel, P; Ndhlovu, P; Nyazema, N; Krarup, H; Michaelsen, KF
      HIV and other predictors of serum beta-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    52. Friis, H; Gomo, E; Koestel, P; Ndhlovu, P; Nyazema, N; Krarup, H; Michaelsen, KF
      HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    53. Nativ, O; Sabo, E; Wald, M; Halachmi, S; Moskovitz, B
      Relationship between prostate size and percent free prostate-specific antigen in patients with operable prostate cancer

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    54. Vaisanen, V; Harma, H; Lilja, H; Bjartell, A
      Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies

      LUMINESCENCE
    55. Semjonow, A; De Angelis, G; Oberpenning, F; Schmid, HP; Brandt, B; Hertle, L
      The clinical impact of different assays for prostate specific antigen

      BJU INTERNATIONAL
    56. Clements, JA; Merritt, T; DeVoss, K; Swanson, C; Hamlyn, L; Scells, B; Rohde, P; Lavin, MF; Yaxley, J; Gardiner, RA
      Inactive free : total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men

      BJU INTERNATIONAL
    57. Lynn, NNK; Collins, GN; O'Reilly, PH
      Prostatic manipulation has a minimal effect on complexed prostate-specificantigen levels

      BJU INTERNATIONAL
    58. Hugosson, J; Aus, G; Becker, C; Carlsson, S; Eriksson, H; Lilja, H; Lodding, P; Tibblin, G
      Would prostate cancer detected by screening with prostate-specific antigendevelop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

      BJU INTERNATIONAL
    59. Patel, D; White, PAE; Ward, AM
      A comparison of six commercial assays for total and free prostate specificantigen (PSA): the predictive value of the ratio of free to total PSA

      BJU INTERNATIONAL
    60. Okegawa, T; Kinjo, M; Watanabe, K; Noda, H; Kato, M; Miyata, A; Murata, A; Yoshii, M; Nutahara, K; Higashihara, E
      The significance of the free-to-complexed prostate-specific antigen (PSA) ratio in prostate cancer detection in patients with a PSA level of 4.1-10.0ng/mL

      BJU INTERNATIONAL
    61. Jung, K; Lein, M; Brux, B; Sinha, P; Schnorr, D; Loening, SA
      Different stability of free and complexed prostate-specific antigen in serum in relation to specimen handling and storage conditions

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    62. Martin, TR; Calella, AM; Silva, S; Munna, E; Modena, P; Chiesa, R; Terrevazzi, S; Ruggieri, RM; Palermo, R; Piccoli, F; Confalonieri, R; Tiraboschi, P; Fragiacomo, C; Quadri, P; Lucca, U; Forloni, G
      Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    63. Licastro, F; Masliah, E; Pedrini, S; Thal, LJ
      Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: Effects of gender and apolipoprotein E genotype

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    64. Ornstein, DK; Englert, C; Gillespie, JW; Paweletz, CP; Linehan, WM; Emmert-Buck, MR; Petricoin, EF
      Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium

      CLINICAL CANCER RESEARCH
    65. Black, MH; Giai, M; Ponzone, R; Sismondi, P; Yu, H; Diamandis, EP
      Serum total and free prostate-specific antigen for breast cancer diagnosisin women

      CLINICAL CANCER RESEARCH
    66. Stege, R; Grande, M; Carlstrom, K; Tribukait, B; Pousette, A
      Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas

      CLINICAL CANCER RESEARCH
    67. Bowman, KK; Clark, J; Yu, LL; Mortara, K; Radika, K; Wang, J; Zhan, HJ
      Expression, purification, and characterization of deglycosylated human pro-prostate-specific antigen

      PROTEIN EXPRESSION AND PURIFICATION
    68. Leinonen, J; Stenman, UH
      Reduced stability of prostate-specific antigen after long-term storage of serum at-20 degrees C

      TUMOR BIOLOGY
    69. Elliott, PR; Pei, XY; Dafforn, TR; Lomas, DA
      Topography of a 2.0 angstrom structure of alpha(1)-antitrypsin reveals targets for rational drug design to prevent conformational disease

      PROTEIN SCIENCE
    70. Wasiluk, A; Dabrowska, M; Jaworski, S; Prokopowicz, J
      The concentration of alpha(1)-antitrypsin in the maternal serum after delivery of normal and small for gestational age infants

      ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE
    71. Tanaka, M; Murakami, S; Suzuki, N; Shimazaki, J
      Change in the ratio of free-to-total prostate-specific antigen during progression of advanced prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    72. Furuya, Y; Akakura, K; Ichikawa, T; Masai, M; Igarashi, T; Ito, H
      Effect of prostatic biopsy on free-to-total prostate-specific antigen ratio in patients with prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    73. Matsuyama, H; Baba, Y; Yamakawa, G; Yamamoto, N; Naito, K
      Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    74. Hull, M; Pasinetti, GM; Aisen, PS
      Elevated plasma neopterin levels in Alzheimer disease

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    75. McIlroy, SP; Vahidassr, MD; Savage, DA; Lloyd, F; Patterson, CC; Lawson, JT; Passmore, AP
      Association of serum AACT levels and AACT signal polymorphism with late-onset Alzheimer's disease in Northern Ireland

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    76. Licastro, F; Pedrini, S; Ferri, C; Casadei, V; Govoni, M; Pession, A; Sciacca, FL; Veglia, F; Annoni, G; Bonafe, M; Olivieri, F; Franceschi, C; Grimaldi, LME
      Gene polymorphism affecting alpha 1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk

      ANNALS OF NEUROLOGY
    77. De Angelis, G; Brandt, B; Schmid, HP; Semjonow, A
      From antigen to tumor marker. Clinical application of PSA research results

      UROLOGE A
    78. Okegawa, T; Noda, H; Nutahara, K; Higashihara, E
      Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer

      EUROPEAN UROLOGY
    79. Martinez, M; Espana, F; Royo, M; Vera, CD; Estelles, A; Jimenez-Cruz, JF; Medina, P; Aznar, J
      Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer

      EUROPEAN UROLOGY
    80. Danisman, A; Kilic, S; Kukul, E; Yakupoglu, G; Guntekin, E; Baykara, M; Sevuk, M
      Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen?

      EUROPEAN UROLOGY
    81. Gion, M; Mione, R; Barioli, P; Barichello, M; Zattoni, F; Prayer-Galetti, T; Plebani, M; Aimo, G; Terrone, C; Manferrari, F; Madeddu, G; Caberlotto, L; Fandella, A; Pianon, C; Vianello, L; Amoroso, B
      Clinical evaluation of percent free prostate-specific antigen using the AxSYM system in the best analytical scenario

      EUROPEAN UROLOGY
    82. Kim, KW; Jhoo, HJ; Lee, KU; Lee, DY; Lee, JH; Youn, JY; Lee, BJ; Woo, JI
      No association between presenilin 1 (PS1) intronic polymorphism and sporadic Alzheimer's disease in Koreans

      JOURNAL OF NEURAL TRANSMISSION
    83. Kordula, T; Bugno, M; Rydel, RE; Travis, J
      Mechanism of interleukin-1-and tumor necrosis factor alpha-dependent regulation of the alpha(1)-antichymotrypsin gene in human astrocytes

      JOURNAL OF NEUROSCIENCE
    84. Mikolajczyk, SD; Millar, LS; Marker, KM; Wang, TJ; Rittenhouse, HG; Marks, LS; Slawin, KM
      Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia

      PROSTATE
    85. Malm, J; Hellman, J; Hogg, P; Lilja, H
      Enzymatic action of prostate-specific antigen (PSA or hK3): Substrate specificity and regulation by Zn2+, a tight-binding inhibitor

      PROSTATE
    86. Wechsel, HW; Gleichmann, R; Blasseneck, J
      The behavior of prostate specific antigen (PSA) and free-PSA (f-PSA) underantihormonal therapy

      ANTICANCER RESEARCH
    87. Lein, M; Jung, K; Elgeti, U; Brux, B; Sinha, P; Schnorr, D; Loening, SA
      Ratio of alpha1-antichymotrypsin - Prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis

      ANTICANCER RESEARCH
    88. Wolff, JM; Ting, O; Borchers, H; Rohde, D; Jakse, G
      Serum levels of prostate specific antigen in men on hemodialysis

      ANTICANCER RESEARCH
    89. Hammerer, P; Graefen, M; Henke, RP; Haese, A; Palisaar, J; Huland, E; Huland, H
      Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy

      ANTICANCER RESEARCH
    90. Dandoy-Dron, F; Benboudjema, L; Guillo, F; Jaegly, A; Jasmin, C; Dormont, D; Tovey, MG; Dron, M
      Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain

      MOLECULAR BRAIN RESEARCH
    91. Licastro, F; Pedrini, S; Caputo, L; Annoni, G; Davis, LJ; Ferri, C; Casadei, V; Grimaldi, LME
      Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation orsignals from the brain?

      JOURNAL OF NEUROIMMUNOLOGY
    92. Bastek, PD; Land, JM; Baumbach, GA; Hammond, DH; Carbonell, RG
      Discovery of alpha-1-proteinase inhibitor binding peptides from the screening of a solid phase combinatorial peptide library

      SEPARATION SCIENCE AND TECHNOLOGY
    93. Tang, GM; Jiang, SD; Zhang, MY; Lin, SC; Qian, YP; Wu, XD; Wang, DX; Jin, TG; Gu, NF
      Genetic association study between alpha 1-antichymotrypsin polymorphism and Alzheimer disease in Chinese Han population

      AMERICAN JOURNAL OF MEDICAL GENETICS
    94. Kim, KW; Jhoo, JH; Lee, KU; Lee, DY; Lee, JH; Youn, JY; Lee, BJ; Han, SH; Woo, JI
      No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans

      AMERICAN JOURNAL OF MEDICAL GENETICS
    95. Jorgensen, M; Vendelbo, B; Skakkebaek, NE; Leffers, H
      Assaying estrogenicity by quantitating the expression levels of endogenousestrogen-regulated genes

      ENVIRONMENTAL HEALTH PERSPECTIVES
    96. Finne, P; Finne, R; Auvinen, A; Juusela, H; Aro, J; Maattanen, L; Hakama, M; Rannikko, S; Tammela, TLJ; Stenman, UH
      Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

      UROLOGY
    97. Catalona, WJ; Southwick, PC; Slawin, KM; Partin, AW; Brawer, MK; Flanigan, RC; Patel, A; Richie, JP; Walsh, PC; Scardino, PT; Lange, PH; Gasior, GH; Loveland, KG; Bray, KR
      Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging

      UROLOGY
    98. Zhang, WM; Finne, P; Leinonen, J; Salo, J; Stenman, UH
      Determination of prostate-specific antigen complexed to alpha(2)-macroclobulin in serum increases the specificity of free to total PSA for prostate cancer

      UROLOGY
    99. Vessella, RL; Lange, PH; Partin, AW; Chan, DW; Sokoll, LJ; Sasse, EA; Crawford, ED
      Probability of prostate cancer detection based on results of a multicenterstudy using the AxSYM free PSA and total PSA assays

      UROLOGY
    100. Becker, C; Piironen, T; Pettersson, K; Hugosson, J; Lilja, H
      Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

      UROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 05:09:36